N
NURO

Natixis’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Natixis’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-6
Closed -$44K – 603
2013
Q4 		$44K Buy
+6
New +$33.7K ﹤0.01% 544

Other funds holding NURO

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Natixis's NURO Position: Q1 2014 in Review

Natixis sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q1 2014, closing a stake of 6 shares — an estimated $44K sold.

Natixis first reported a position in NURO in Q4 2013 and held it in 1 quarter. The position peaked at $44K in Q4 2013. 7 funds tracked by Wall St. Rank hold NURO as of Q1 2014.

  • Natixis reported no remaining NeuroMetrix, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Natixis sold 6 NeuroMetrix, Inc. Common Stock shares in Q1 2014, an estimated $44K.
  • Natixis first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2013 and held it in 1 quarter.
  • Natixis's NeuroMetrix, Inc. Common Stock position peaked at $44K in Q4 2013.
  • 7 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q1 2014.

Based on Natixis's 13F filing for Q1 2014, filed 14 May 2014.